Otitis Media

  • Leslie Michaels
  • Henrik B. Hellquist


Infection of the middle ear causes not only generally known inflammatory changes but also others peculiar to the site. Otitis media is one of the most common of all diseases, particularly in young children. The clinical forms of the acute and chronic conditions correspond to the pathological changes, but intermediate or mixed states are frequent. Perforation of the tympanic membrane may occur at any phase of otitis media, but an effusion is often present behind an intact tympanic membrane. It is important that an advanced degree of otitis media may exist, but may remain undetected clinically and even be undetectable.1


Otitis Medium Tympanic Membrane Acute Otitis Medium Otitis Medium With Effusion Chronic Otitis Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paparella MM, Kimberley BP, Alleva M. The concept of silent otitis media. Its importance and implications. Otolaryngol Clin N Amer 1991;24:763–773Google Scholar
  2. 2.
    Sugita R, Fujimaki Y, Deguchi K. Bacteriological features and chemotherapy of adult acute purulent otitis media. J Laryngol Otol 1985;99:629–635PubMedCrossRefGoogle Scholar
  3. 3.
    Brook I, Anthony BF, Finegold SM. Aerobic and anaerobic bacteriology of acute otitis media in children. J Ped 1978;92:13–16CrossRefGoogle Scholar
  4. 4.
    Henderson FW, Collier AM, Sanyal MA et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306:1377–1383PubMedCrossRefGoogle Scholar
  5. 5.
    Chonmaitree T, Howie VM, Truant AL. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 1986;77:698–702PubMedGoogle Scholar
  6. 6.
    Buchman CA, Doyle WJ, Skoner DP et al. Influenza A virusinduced acute otitis media. J Infect Dis 1995;172:1348–1351PubMedCrossRefGoogle Scholar
  7. 7.
    Catanzaro A, Ryan A, Batcher S et al. The response to human RIL-1, RIL-2, and RTNF in the middle-ear of guinea-pigs. Laryngoscope 1991;101:271–275PubMedCrossRefGoogle Scholar
  8. 8.
    Yellon RF, Leonard G, Marucha PT et al. Characterization of cytokines present in middle-ear effusions. Laryngoscope 1991;101:165–169PubMedCrossRefGoogle Scholar
  9. 9.
    Amar MS, Wishahi HF, Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol 1996;110:534–539PubMedCrossRefGoogle Scholar
  10. 10.
    Tos M, Bak-Pedersen K. Goblet cell population in the normal middle ear and Eustachian tube of children and adults. Ann Otol Rhinol Laryngol 1976;85(suppl 25):44–50PubMedGoogle Scholar
  11. 11.
    Tos M, Bak-Pedersen K. Goblet cell population in the pathological middle ear and Eustachian tube of children and adults. Ann Otol Rhinol Laryngol 1977;86:209–218PubMedGoogle Scholar
  12. 12.
    Albrecht W. Pneumatisation und Konstitution. Z Hals— Nasen-und Ohrenheilkunde 1924;10:51–55Google Scholar
  13. 13.
    Sadé J, Teitz A. Cholesterol in cholesteatoma and in the otitis media syndrome. In: Sadé J (ed) Cholesteatoma and mastoid surgery. Proceedings of the second international conference. Kugler, Amsterdam, 1982, pp 125–132Google Scholar
  14. 14.
    Goldstein NA, Roland JT, Sculerati NN. Complications of tympanostomy tubes in an inner-city clinic population. Int J Pediatr Otorhinolaryngol 1996;34:87–99PubMedCrossRefGoogle Scholar
  15. 15.
    Politzer A. Das Cholesteatom des Gehörgans vom anatomischen und klinischen Standpunkte, Wiener Medizinische Wochenschrift 1891;8:329–333Google Scholar
  16. 16.
    McKenzie D. The pathogeny of aural cholesteatoma. Proc Roy Soc Med 1931;24:332–362PubMedGoogle Scholar
  17. 17.
    Palva T, Karma P, Makinen J. The invasion theory. In: Sadé J. (ed) Cholesteatoma and mastoid surgery. Proceedings of the second international conference. Kugler, Amsterdam, 1982, pp 249–264Google Scholar
  18. 18.
    Frankel S, Berson S, Godwin T et al. Differences in dendritic cells in congenital and acquired cholesteatomas. Laryngoscope 1993;103:1214–1217PubMedCrossRefGoogle Scholar
  19. 19.
    Van Blitterswijk CA, Grote JJ, Lutgert RW et al. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis. Ann Otol Rhinol Laryngol 1989;98:635–640PubMedGoogle Scholar
  20. 20.
    Lee RL, Sidey C, Narula AA et al. The nature of the epithelium in acquired cholesteatoma: part 3 — cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture. Clin Otolaryngol 1994;19:516–520PubMedCrossRefGoogle Scholar
  21. 21.
    Broekaert D, Couke P, Leperque S. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann Otol Rhinol Laryngol 1992;101:931–938PubMedGoogle Scholar
  22. 22.
    Litton WB. Epithelial migration in the ear: the location and characteristics of the generation centre revealed by utilizing a radioactive desoxyribose nucleic acid precursor. Acta Otolaryngol (Stockh) 1968;240(suppl):l–39Google Scholar
  23. 23.
    Bajia J, Schilling V, Holly A et al. Hyperproliferation-associated expression in human middle ear cholesteatoma. Acta Otolaryngol 1993;113:364–368CrossRefGoogle Scholar
  24. 24.
    Sudhoff H, Bujia J, Fisselereckhoff A et al. Expression of a cell-cycle-associated nuclear antigen (MIB1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995;105:1227–1231PubMedCrossRefGoogle Scholar
  25. 25.
    Sudhoff H, Fisseler-Eckhoff A, Stark T et al. Argyrophilic nucleolar organizer regions in auditory meatal skin and middle ear cholesteatoma. Clin Otolaryngol 1997; 22:545–548PubMedCrossRefGoogle Scholar
  26. 26.
    Youngs R, Rowles P. The spatial organisation of keratinocytes in acquired middle ear cholesteatoma resembles that of external canal skin and pars flaccida. Acta Otolaryngol (Stockh) 1990;110:115–119CrossRefGoogle Scholar
  27. 27.
    Stammberger M, Bujia J, Kastenbauer E. Alteration in epidermal differentiation in cholesteatoma. Am J Otol 1995;4:527–531Google Scholar
  28. 28.
    Sudhoff H, Bujia J, Holly A et al. Functional characterization of middle ear mucosa residues in cholesteatomatous samples. Am J Otol 1994;15:217–221PubMedGoogle Scholar
  29. 29.
    Proops DW, Hawke WM, Parkinson EK. Tissue-culture of migratory skin of the external ear and cholesteatoma — a new research tool. J Otolaryngol 1984;13:63–69PubMedGoogle Scholar
  30. 30.
    Boxall JD, Proops DW, Michaels L. The specific locomotive activity of tympanic membrane and cholesteatoma epithelium in tissue culture. J Otolaryngol 1988;17:140–144PubMedGoogle Scholar
  31. 31.
    Cheshire IM, Blight A, Proops DW. An in-vitro growth study on cholesteatoma and normal skin. Clin Otolaryngol 1995;20:453–456PubMedCrossRefGoogle Scholar
  32. 32.
    Ruedi L. Cholesteatoma formation in the middle ear in animal experiments. Acta Otolaryngol (Stockh) 1959; 50:233–242CrossRefGoogle Scholar
  33. 33.
    Fernandez C, Lindsay JR. Aural cholesteatoma: experimental observations. Laryngoscope 1960;70:1119–1141PubMedGoogle Scholar
  34. 34.
    Friedmann I. The comparative pathology of otitis media. Experimental and human. 11. The histopathology of experimental otitis of the guinea pig with particular reference to experimental cholesteatoma. J Laryngol Otol 1955;69:588–601PubMedCrossRefGoogle Scholar
  35. 35.
    Wright CG, Meyerhoff WL, Burns DK. Middle ear cholesteatoma: an animal model. Am J Otolaryngol 1985; 6:327–341PubMedCrossRefGoogle Scholar
  36. 36.
    Masaki M, Wright CG, Lee DH et al. Experimental cholesteatoma. Epidermal ingrowth through tympanic membrane following middle ear application of propylene glycol. Acta Otolaryngol (Stockh) 1989;108:113–121CrossRefGoogle Scholar
  37. 37.
    Palva T, Johnsson L. Findings in a pair of temporal bones from a patient with secretory otitis media and chronic middle ear infection. Acta Otolaryngol 1984;98:208–220PubMedCrossRefGoogle Scholar
  38. 38.
    Wells MD, Michaels L. Role of retraction pockets in cholesteatoma formation. Clin Otolaryngol 1983;8:39–45PubMedCrossRefGoogle Scholar
  39. 39.
    Schuknecht HE Pathology of the ear, 2nd edn. Lea & Febiger, Philadelphia, 1993Google Scholar
  40. 40.
    Ruedi L. Pathogenesis and treatment of cholesteatoma in chronic suppuration of the temporal bone. Ann Otol Rhinol Laryngol 1957;66:283–304PubMedGoogle Scholar
  41. 41.
    Choie RA. Experimental retraction pocket cholesteatoma. Ann Otol Rhinol Laryngol 1986;95:639–641Google Scholar
  42. 42.
    Chole RA, Henry KR, McGinn D. Cholesteatoma: spontaneous occurrence in the Mongolian gerbil, Meriones unguiculatis. Am J Otol 1981;2:204–210PubMedGoogle Scholar
  43. 43.
    McGinn MD, Chole RA, Henry KR. Cholesteatoma induction. Consequences of external auditory canal ligations in gerbils, cats, hamsters, guinea-pigs, mice and rats. Acta Otolaryngol Stockh 1984;97:297–304PubMedCrossRefGoogle Scholar
  44. 44.
    Sadé J. The biopathology of secretory otitis media. Ann Otol Rhinol Laryngol 1974;11(suppl):59–70Google Scholar
  45. 45.
    Chole RA. Squamous metaplasia of the middle ear mucosa during vitamin A deprivation. Otolaryngol Head Neck Surg 1979;87:837–844PubMedGoogle Scholar
  46. 46.
    Kronenburg J, Ben-Shoshan J, Modam M et al. Blast injury and cholesteatoma. Am J Otol 1988;9:127–130CrossRefGoogle Scholar
  47. 47.
    Friedberg J. Congenital cholesteatoma. Laryngoscope 1994;104(suppl):1–24PubMedCrossRefGoogle Scholar
  48. 48.
    Derlacki EL. Congenital cholesteatoma of the middle ear and mastoid: a third report. Arch Otolaryngol. J 1973;97:177–182CrossRefGoogle Scholar
  49. 49.
    McGill TJ, Merchant S, Healy GB et al. Congenital cholesteatoma of the middle ear in children: a clinical and histopathological report. Laryngoscope 1991;101:606–613PubMedCrossRefGoogle Scholar
  50. 50.
    Grundfast KM, Ahuja GS, Parisier SC et al. Delayed diagnosis and fate of congenital cholesteatoma (keratoma). Arch Otolaryngol Head Neck Surg 1995;121:903–907PubMedCrossRefGoogle Scholar
  51. 51.
    Cohen D. Locations of primary cholesteatoma. Am J Otol 1987;8:61–65PubMedGoogle Scholar
  52. 52.
    lino Y, Imamura Y, Hiraishi M et al. Mastoid pneumatization in children with congenital cholesteatoma: an aspect of the formation of open-type and closed-type cholesteatoma. Laryngoscope 1998;108:1071–1076CrossRefGoogle Scholar
  53. 53.
    Jaisinghani VJ, Paparella MM, Schachern PA. Silent intratympanic membrane cholesteatoma. Laryngoscope 1998;108:1185–1189.PubMedCrossRefGoogle Scholar
  54. 54.
    Teed RW. Cholesteatoma verum tympani: its relationship to the first epibranchial placode. Arch Otolaryngol 1936;24:455–474CrossRefGoogle Scholar
  55. 55.
    Michaels L. An epidermoid formation in the developing middle ear; possible source of cholesteatoma. J Otolaryngol 1986;15:169–174PubMedGoogle Scholar
  56. 56.
    Wang R-G, Hawke M, Kwok P. The epidermoid formation (Michaels’ structure) in the developing middle ear. J Otolaryngol 1987;16:327–330PubMedGoogle Scholar
  57. 57.
    Eggston A, Wolff D. Histopathology of the ear, nose and throat. Williams and Wilkins Co., Baltimore, 1947, p 432Google Scholar
  58. 58.
    Northrop C, Piza J, Eavey RD. Histological observations of amniotic fluid cellular content in the ear of neonates and infants. Int J Pediatr Otorhinolaryngol 1986;11:113–127PubMedCrossRefGoogle Scholar
  59. 59.
    Abramson M, Huang C. Cholesteatoma and bone resorption. In: McCabe BF et al. (eds) Cholesteatoma. First international conference. Aesculapius, Birmingham Ala, 1977, pp 162–166Google Scholar
  60. 60.
    Yin ET. Endotoxin, thrombin and the limulus amebocyte lysate test. J Lab Clin Med 1975;86:430–434PubMedGoogle Scholar
  61. 61.
    Ishii T, Toriyama M, Suzuki J–I. Histopathological study of otitis media with effusion. Ann Otol Rhinol Laryngol 1980;89(suppl68):83–86Google Scholar
  62. 62.
    Michaels L, Soucek S, Liang J. The ear in the acquired immunodeficiency syndrome: I. Temporal bone histopathologic study. AmeJ Otol 1994;15:515–522Google Scholar
  63. 63.
    Buchanan G, Rainer EH. Tuberculous mastoiditis. J Laryngol Otol 1988;102:440–446PubMedCrossRefGoogle Scholar
  64. 64.
    Tyndel FJ, Davidson GS, Birman H et al. Sarcoidosis of the middle ear. Chest 1994;105:1582–1583PubMedCrossRefGoogle Scholar
  65. 65.
    Macias JD, Wackym PA, McCabe BF. Early diagnosis of otologic Wegener’s granulomatosis using the serologic marker C-ANCA. Ann Otol Rhinol Laryngol 1993;102:337–341PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2001

Authors and Affiliations

  • Leslie Michaels
    • 1
    • 2
    • 3
  • Henrik B. Hellquist
    • 4
    • 5
  1. 1.Department of Histopathology, UCL Medical SchoolRockefeller BuildingLondonUK
  2. 2.Royal Free and UCL Medical SchoolUniversity of LondonUK
  3. 3.Royal National Throat, Nose nad Ear HospitalLondonUK
  4. 4.Department of Laboratory Medicine and PathologyHamad Medical CorporationDohaQatar
  5. 5.Haukeland University HospitalBergenNorway

Personalised recommendations